modelDiltiazem_Klle1983_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.

Information

name:diltiazem
ATC code:C08DB01
model:one compartment, IV dosing (PK_1C)
source:Kölle EU et al. 1983
population:healthy subjects
measured compound:diltiazem
review:curated candidate
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
t1/2 alpha0.1ht1/2α
t1/2 beta2.1ht1/2β
t1/2 gamma9.8ht1/2γ
Vc0.9l/kgV
Vss5.2l/kgVss
Cltot11.5ml/min/kgCL
mean hepatic extraction ratio0.54meanEH

About diltiazem

Diltiazem is a calcium channel blocker used to treat high blood pressure, angina, and certain heart rhythm problems such as atrial fibrillation and supraventricular tachycardia. It is an approved medicine and is widely used for these cardiovascular conditions.

Summary written by glm-5.3-flash from Wikidata Q422229 and the WHO ATC classification; not checked by a person.

Identity, molar mass and metabolites: Diltiazem.

References

  1. Kölle EU et al. (1983). Pharmacokinetic model of diltiazem. Arzneimittel-Forschung 33(7):972–977. PUBMED:6684932

Parameters

TypeNameDefaultDescription
RealCl_ref1.3416666666666668e-05Cl [m3/s]
RealVd_ref0.063Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Kölle_1983: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate